Graft Polymer (UK) PLC ( (GB:GPL) ) just unveiled an update. Graft Polymer (UK) Plc announced the successful approval of a name change to Solvonis Therapeutics plc following a general meeting.

Graft Polymer (UK) Plc plans to rebrand as Solvonis Therapeutics Plc, aligning its identity with a strategic focus on mental health and substance use disorder treatments. The company highlights ...

Graft Polymer said it will begin production immediately on the US$1mln order for an anti-inflammatory supplement that will be sold in the US market.

(Alliance News) - Graft Polymer (UK) PLC on Monday said it will collaborate with the Slovenian Faculty of Polymer Technology to research and produce vitrimer polymer products.

Graft Polymer (UK) plc has announced a research agreement between its partner, Awakn Life Sciences Corp., and the University of Nottingham. The agreement covers in vivo research to evaluate the ...

Graft Polymer (UK) PLC has signed a research and development and supply agreement with Empresas Vilher, a Mexican company that specialises in wood plastic composite, plastic recycling and high ...

New study details a polymer-grafting approach for creating surface-functionalized MOF nanosheets, highlighting a significant advancement in the field of material science and its potential impact on ...

Graft Polymer (UK) ( LON:GPL ) Full Year 2023 Results Key Financial Results Revenue: UK£587.0k (up 8.3% from FY 2022 ...

Graft Polymer said Gabriel Chemie has committed to purchase from Graft Polymer their Graftalloy, Graftakit, Graftasynt, Graftalen and Graftabond products.

(Graft Polymer (UK) PLC (LSE:GPL) CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the company’s plans to acquire Canadian biotech Awakn Life Sciences. Tennyson explained the ...